Your Migraine Index

Migraine Drug Section


Welcome to Your Migraine Index

migraine drug Links

MAGNUM Inc.
Migraine Awareness Group: a National Understanding for Migraineurs.

Anti-Migraine Drug Warning For Those With Heart Disease
Science News, Science Discussion, Research And Scientific Hot Topics.

New Migraine Drug Shows Promise
Early studies suggest that a novel migraine treatment is as effective as the best available drugs, and can alleviate pain hours after a migraine starts. ... New Migraine Drug Shows Promise. May Work Even on Severe or Moderate Pain That Has Lasted for ... The novel drug was effective for treating migraine attacks characterized as moderate ...

Excedrin Migraine Drug Information
Excedrin Migraine Drug Information from Drugs.com. Includes side effects,
interactions, indications.

Epilepsy Drug Fights Migraine
... Epilepsy Drug Fights Migraine. Topamax Prevents Chronic Migraines ... researchers found treatment with the drug Topamax cut the number of migraine episodes in half for more than ...

Migraine Headaches - UMMC
WHAT ARE THE SPECIFIC DRUGS AND REMEDIES FOR TREATING A MIGRAINE ATTACK? ...
They do not have the sedative effect of other migraine drugs. ...

Modern Drug Discovery: Forged in St. Anthony's Fire: Drugs for Migraine
Modern Drug Discovery. March/April 1999. Modern Drug Discovery, 1999, 2 (2), 20-21, 23-24, 28, 31. Copyright © 1999 by the American Chemical Society. ... the first effective migraine medications and has been a springboard for further migraine drug development ...




migraine drug News

Morning Break: 35 U.S. COVID-19 Cases; IV Migraine Drug OK'd; Medical Error Meltdowns

On Friday, the FDA approved the first intravenous treatment to prevent migraine, Lundbeck's eptinezumab (Vyepti), which will be available in April. The agency also green-lighted Asuragen's AmplideX ...

Read more...


Migraine Drugs Market To Reach USD 3.51 Billion By 2026 | Reports And Data

New York, Feb. 24, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global Migraine Drugs market was valued at USD 1.29 billion in 2018 and is expected to reach USD ...

Read more...


Meta-Analysis Suggested That Biohaven Pharmaceutical's Migraine Prevention Trial Is Highly Likely To Succeed

Traditionally, migraines with mild and moderate symptoms are managed by nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. Triptans are considered more effective and are usually recommended ...

Read more...


FDA Approves First IV Migraine Prevention Drug

The US Food and Drug Administration has approved eptinezumab-jjmr (Vyepti, Lundbeck), the first intravenous (IV) migraine prevention medication, the company has announced. As previously reported by ...

Read more...


Lundbeck’s Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

A migraine drug that Lundbeck added to its pipeline via its nearly $2 billion acquisition of Alder BioPharmaceuticals won FDA approval on Friday. The drug, eptinezumab (Vyepti), is part of a new class ...

Read more...


FDA approves Vyepti, first IV preventive treatment for migraine

clinical pharmacists and patients were an “effective and efficient way” to educate patients about the CGRP blockers for migraine prevention, according to researchers at the American Headache Society ...

Read more...